School of Medicine

From its humble beginning as a mimeographed, five-page news-sheet to today’s four-color, 36-page, high-quality glossy magazine and multimedia online presence, Outlook magazine has long been the featured source of information about the people and events of Washington University School of Medicine. Now complete issues of Outlook, from 1964-2011, are available in PDF format.

Washington University’s Bear Cub Fund is soliciting grant applications from WUSTL researchers who want to move inventions from their laboratories toward commercialization.The application deadline is Nov. 30.

People visiting the Center for Advanced Medicine (CAM) on the campus of Washington University School of Medicine might be surprised to hear live music as they arrive at the facility’s bustling lobby. But for the past decade, the CAM has offered not only patient care at nearly two dozen treatment centers and the Alvin J. Siteman Cancer Center, but also a tradition of impromptu entertainment.

The Department of Cell Biology and Physiology at Washington University School of Medicine in St. Louis marks its 100th anniversary this month with a series of events, including lectures and a symposium featuring some of today’s most visionary scientific thinkers.

Plan to visit this fall’s Health Happening health and wellness fair, titled “Walk this Way.” The fair will be held from 7:30 a.m.-2:30 p.m. Oct. 28 in the McDonnell Pediatric Research Building atrium. It is open to university faculty, staff and students.

Itching is one of the most prevalent side effects of powerful, pain-killing drugs like morphine, oxycodone and other opioids. For many years, scientists have scratched their own heads about why the drugs so often induce itch while they are suppressing pain. Now researchers at Washington University School of Medicine in St. Louis have shown they can control the opioid-induced itching without interfering with a drug’s ability to relieve pain.  

Scientists have developed a way to evaluate new treatments for some forms of attention deficit disorder. Working in mice, researchers at the School of Medicine showed that they can use brain scans to quickly test whether drugs increase levels of dopamine. The same group found that raising dopamine levels in mice alleviates attention deficits caused by neurofibromatosis type 1 (NF1), a condition that affects more than 100,000 people in the United States.

Washington University in St. Louis has received a five-year, $3 million grant to establish a new center to develop better ways to prevent and treat type 2 diabetes in high-risk patients, including American Indians and Alaska Natives, says Debra Haire-Joshu, PhD, director of the new center. 

A draft recommendation by the U.S. Preventive Services Task Force calling for an end to routine PSA testing for healthy men age 50 and older goes too far, says Gerald Andriole, MD, a prostate cancer expert at Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis.

The Children’s Discovery Institute has approved funding for three large-scale research initiatives focusing on heart and lung diseases in children. Together, the projects will receive $1.5 million over three years.The institute is a multi-disciplinary, innovation-based research partnership between St. Louis Children’s Hospital and the School of Medicine that has awarded more than $23 million in scientific grants since its launch in 2006.